Henry Schein has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The ...

Henry Schein is expected to report impressive sales in both its businesses in the fourth quarter of 2024, along with a positive pace of recovery from the cyber incident.

Chevy Chase Trust Holdings LLC cut its holdings in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 3.9% during the fourth quarter, according to the company in its most recent 13F filing with the ...

Savant Capital LLC boosted its position in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 43.9% in the 4th quarter, ...

Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of Henry Schein (NasdaqGS:HSIC) with a Equal-Weight ...

The American Dental Association Foundation (ADA Foundation) is celebrating the 23rd year of its Give Kids A Smile® (GKAS) ...

BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...

former CEO of Henry Schein's Global Dental Group, and A.J. Caffentzis, former president of its U.S. dental division. The departures raised concerns that top executives who might have been ...

Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is paying tribute to women athletic ...

NEW YORK, Jan 22 (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein, arguing the dental and medical ...